XTL Biopharmaceuticals names two new board members

In addition, Mr Grossman will also be assuming the role of co-CEO, with no remuneration, to assist in XTL’s analysis of its strategic alternatives.

Mr Grossman served as a vice president of Eurocom Investments, a private equity fund focused on long-term investments mainly in Israeli public companies, from March 2006 to December 2008. Mr Grossman has received a BA business administration with a focus on information technology, from the Interdisciplinary Center Herzliya.

Mr Shweiger has served as a partner and managing director of Sean Holdings, a private investment company, since August 2005. Mr Shweiger has received an LLB, magna cum laude, from the College of Management and an MBA in finance and auditing from Tel-Aviv University.